Cargando…
Senolytics alleviate the degenerative disorders of temporomandibular joint in old age
Aging is one of the major risk factors for degenerative joint disorders, including those involving the temporomandibular joint (TMJ). TMJ degeneration occurs primarily in the population over 65, significantly increasing the risk of joint discomfort, restricted joint mobility, and reduced quality of...
Autores principales: | Zhou, Yueying, Al‐Naggar, Iman M. A., Chen, Po‐Jung, Gasek, Nathan S., Wang, Ke, Mehta, Shivam, Kuchel, George A., Yadav, Sumit, Xu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282237/ https://www.ncbi.nlm.nih.gov/pubmed/34101970 http://dx.doi.org/10.1111/acel.13394 |
Ejemplares similares
-
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
por: Roos, Carolyn M., et al.
Publicado: (2016) -
Transplanting cells from old but not young donors causes physical dysfunction in older recipients
por: Wang, Binsheng, et al.
Publicado: (2020) -
Temporomandibular joint aging and potential therapies
por: Zhou, Yueying, et al.
Publicado: (2021) -
The SIRT6 activator MDL‐800 improves genomic stability and pluripotency of old murine‐derived iPS cells
por: Chen, Yu, et al.
Publicado: (2020) -
Senescence‐induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics
por: Lorenzo, Erica C., et al.
Publicado: (2021)